A role of macrophages on antiphospholipid syndrome : antigen presenting and mechanisms on thrombosis
巨噬细胞在抗磷脂综合征中的作用:抗原呈递和血栓形成机制
基本信息
- 批准号:14570120
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The oxidative modification of low-density lipoprotein (LDL) in the intima of arteries contributes to the initiation and progression of atherosclerotic lesions. Antiphospholipid syndrome (APS) is an autoimmune disease that causes autoantibody-mediated thrombosis. We have recently found that APS derived-IgG immune complexes with oxidized LDL (oxLDL) and β2-glycoprotein I (β2GPI) were taken up by macrophages and results in forming foam cells.In the present study, we fist analyzed interactions between oxLDL and β2GPI and identified the oxLDL-derived lipid ligands (oxidized lipids) for β2GPI binding. Then, relationship was studied between β2GPI binding to antigen presenting cells, such as macrophages and dendritic cells, and their antigen presenting to β2GPI-specific T cell cones. Further, effect of IgM natural antibodies from hyperlipidemic mice and human subjects on in vitro oxLDL uptake by macrophages were studied, as compared with APS-derived IgG autoantibodies.Antigen presenting was not observed when β2GPI alone was added to culture but was together with liposomes containing negatively charged phospholipids or β2GPI-specific ligands from oxLDL. However, there were not good correlation between binding of β2GPI to macrophages and β2GPI-specific T cell proliferation (i.e., antigen presentation). Antigen processing and presentation may be regulated by trafficking way of lipids that were associated with β2GPI to be uptaken by macrophages. Not like IgG anti-β2GPI autoantibodies, IgM anti-oxLDL natural antibodies prevented oxLDL uptake by macrophages. Macrophages have dual important roles, i.e., not only on lipid metabolism but also on antigen presenting. In the future studies, it must be important to clarify the dual roles of macrophages on natural and autoimmunity.
动脉内膜低密度脂蛋白(LDL)的氧化修饰参与动脉粥样硬化病变的发生和发展。抗磷脂综合征(APS)是一种自身免疫性疾病,可导致自身抗体介导的血栓形成。我们最近发现,APS衍生的免疫球蛋白与氧化型低密度脂蛋白(OxLDL)和β2-糖蛋白I(β2GPI)被巨噬细胞摄取并形成泡沫细胞。在本研究中,我们首先分析了oxLDL与β2GPI之间的相互作用,并确定了与β2GPI结合的oxLDL衍生的脂质配体(氧化脂)。然后,研究了β2GPI与巨噬细胞、树突状细胞等抗原提呈细胞的结合及其与β2GPI特异性T细胞的抗原提呈之间的关系。进一步研究了来自高脂血症小鼠和人的免疫球蛋白M天然抗体对巨噬细胞体外摄取氧化低密度脂蛋白的影响,并与β2GPI单独加入培养物时没有观察到抗原呈递,而与含有带负电荷的磷脂或来自氧化低密度脂蛋白的β2GPI特异性配体的脂质体一起作用。然而,β2GPI与巨噬细胞的结合与β2GPI特异性T细胞增殖(即抗原提呈)之间没有很好的相关性。巨噬细胞摄取与β2GPI相关的脂类,可能通过转运途径调节抗原的加工和提呈。与Ig G抗β2GPI自身抗体不同,Ig M抗oxLDL天然抗体可阻止巨噬细胞摄取oxLDL。巨噬细胞具有双重重要作用,即不仅参与脂类代谢,而且还参与抗原递呈。在未来的研究中,阐明巨噬细胞在自然免疫和自身免疫中的双重作用是非常重要的。
项目成果
期刊论文数量(84)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Wu, R., Matsuura, E.et al.: "Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations-possible immunomodulation of atherosclerosis."Autoimmunity. 36. 91-97 (2003)
Wu, R., Matsuura, E.等人:“静脉内免疫球蛋白制剂中氧化 LDL 抗体的抗独特型 - 可能对动脉粥样硬化进行免疫调节。”自身免疫。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kasahara, J., Matsuura, E.et al.: "Clinical significance of serum oxidized LDL in patients with chronic renal diseases"Nephron Clin.Practice. (in press). (2004)
Kasahara, J., Matsuura, E.等人:“慢性肾病患者血清氧化低密度脂蛋白的临床意义”Nephron Clin.Practice。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
小林和子, 松浦栄次, 他: "血小板と生理活性脂質 章(脂質の酸化と生理活性)執筆 (尾崎由基男、池田康夫、島田和幸、高井義美、丸山征朗編)"金芳堂(東京). 147-160 (2002)
Kazuko Kobayashi、Eiji Matsuura 等:“血小板和生理活性脂质篇(脂质的氧化和生理活性)”(编辑:Yukio Ozaki、Yasuo Ikeda、Kazuyuki Shimada、Yoshimi Takai、Seiro Maruyama)、Konpodo(东京)。 147-160 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Liu, Q., Matsuura, E.et al.: "ω-Carboxyl variants of 7-ketocholesteryl esters are ligands for β2-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages"J.Lipid Res.. 43(9). 1486-1495 (2002)
Liu, Q., Matsuura, E.等人:“7-酮胆固醇酯的 ω-羧基变体是 β2-糖蛋白 I 的配体,介导巨噬细胞对氧化 LDL 的抗体依赖性摄取”J.Lipid Res.. 43( 9). 1486-1495 (2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Lopez, D., Matsuura, E.et al.: "IgG autoantibodies against β2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome"Clin.Dev.Immunol.. 10. 223-211 (2
Lopez, D.、Matsuura, E. 等人:“针对 β2-糖蛋白 I 的 IgG 自身抗体与源自氧化低密度脂蛋白的脂质配体复合,与抗磷脂综合征中的动脉血栓形成相关”Clin.Dev.Immunol.. 10 223-211(2.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUURA Eiji其他文献
MATSUURA Eiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUURA Eiji', 18)}}的其他基金
Development of a novel radiological-photo-therapy essential for Theranostics targeting deep lesions
开发一种对于针对深层病变的治疗诊断至关重要的新型放射光疗法
- 批准号:
16K15582 - 财政年份:2016
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Establishment of Molecular Imaging and Lipidomics Technologies for Early Diagnosis of Atherosclerotic Disease
建立动脉粥样硬化疾病早期诊断的分子影像和脂质组学技术
- 批准号:
26253036 - 财政年份:2014
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of a PET imaging system for cancer diagnosis using Zr-89 lableled anti-mesothelin scFv
使用 Zr-89 标记的抗间皮素 scFv 开发用于癌症诊断的 PET 成像系统
- 批准号:
25670273 - 财政年份:2013
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of targeted therapy of cancer cells with diagnostic imaging through the application of immunoliposomes
通过免疫脂质体的应用开发诊断成像的癌细胞靶向治疗
- 批准号:
23659299 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of targeted medical care (simultaneous diagnostic imaging and therapy) for pathogenic angiogenesis using fibrinolytic metabolites
利用纤溶代谢物开发针对致病性血管生成的靶向医疗护理(同时诊断成像和治疗)
- 批准号:
23390151 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Physiological role of 11-dehydrothromboxane B2 : parameter of platelet activity and aspirin resistance
11-脱氢血栓烷 B2 的生理作用:血小板活性和阿司匹林抵抗的参数
- 批准号:
20590573 - 财政年份:2008
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathobiochemical and immunological study on infection-accelerated atherosclerosis and its regulation.
感染加速动脉粥样硬化及其调控的病理生化和免疫学研究。
- 批准号:
18590296 - 财政年份:2006
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome
抗磷脂综合征中 Beta-2 糖蛋白 I 的结构研究
- 批准号:
10320750 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别:
Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome
抗磷脂综合征中 Beta-2 糖蛋白 I 的结构研究
- 批准号:
10561597 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别:
A prospective study evaluating complement activation among pregnant patients with obstetrical antiphospholipid syndrome
一项评估产科抗磷脂综合征妊娠患者补体激活的前瞻性研究
- 批准号:
405079 - 财政年份:2019
- 资助金额:
$ 2.18万 - 项目类别:
Operating Grants
Molecular Basis of Pregnancy Complications in the Antiphospholipid Syndrome
抗磷脂综合征妊娠并发症的分子基础
- 批准号:
9764402 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
Preparation of diagnostic guidelines for antiphospholipid syndrome and elucidation of the mechanism for arterial and venous thrombosis.
制定抗磷脂综合征诊断指南并阐明动静脉血栓形成机制。
- 批准号:
18K07468 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synergistic effects of antiphospholipid antibodies and oxidative stress that increase the risk of thrombosis in antiphospholipid syndrome
抗磷脂抗体和氧化应激的协同作用会增加抗磷脂综合征中血栓形成的风险
- 批准号:
18K16117 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular Basis of Pregnancy Complications in the Antiphospholipid Syndrome
抗磷脂综合征妊娠并发症的分子基础
- 批准号:
10183277 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
Molecular Basis of Pregnancy Complications in the Antiphospholipid Syndrome
抗磷脂综合征妊娠并发症的分子基础
- 批准号:
10411934 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
Molecular Basis of Pregnancy Complications in the Antiphospholipid Syndrome
抗磷脂综合征妊娠并发症的分子基础
- 批准号:
9922707 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
MICA: Development of PEGylated Domain I of beta-2-glycoprotein I as a new therapeutic agent for the antiphospholipid syndrome
MICA:开发 β-2-糖蛋白 I 的聚乙二醇化结构域 I 作为抗磷脂综合征的新治疗剂
- 批准号:
MR/P017371/1 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
Research Grant














{{item.name}}会员




